This company has been marked as potentially delisted and may not be actively trading. AzurRx BioPharma (AZRX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AZRX vs. ABVC, IPA, MEIP, IMNN, PHIO, LSB, RLMD, TXMD, NERV, and QNTMShould you be buying AzurRx BioPharma stock or one of its competitors? The main competitors of AzurRx BioPharma include ABVC BioPharma (ABVC), ImmunoPrecise Antibodies (IPA), MEI Pharma (MEIP), Imunon (IMNN), Phio Pharmaceuticals (PHIO), Lakeshore Biopharma (LSB), Relmada Therapeutics (RLMD), TherapeuticsMD (TXMD), Minerva Neurosciences (NERV), and Quantum Biopharma (QNTM). These companies are all part of the "medical" sector. AzurRx BioPharma vs. ABVC BioPharma ImmunoPrecise Antibodies MEI Pharma Imunon Phio Pharmaceuticals Lakeshore Biopharma Relmada Therapeutics TherapeuticsMD Minerva Neurosciences Quantum Biopharma AzurRx BioPharma (NASDAQ:AZRX) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk. Does the MarketBeat Community believe in AZRX or ABVC? AzurRx BioPharma received 225 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformAzurRx BioPharmaOutperform Votes22574.26% Underperform Votes7825.74% ABVC BioPharmaN/AN/A Is AZRX or ABVC more profitable? AzurRx BioPharma has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat AzurRx BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets AzurRx BioPharmaN/A -482.96% -258.47% ABVC BioPharma -1,619.65%-104.94%-56.81% Does the media prefer AZRX or ABVC? In the previous week, ABVC BioPharma had 3 more articles in the media than AzurRx BioPharma. MarketBeat recorded 3 mentions for ABVC BioPharma and 0 mentions for AzurRx BioPharma. ABVC BioPharma's average media sentiment score of 0.46 beat AzurRx BioPharma's score of 0.00 indicating that ABVC BioPharma is being referred to more favorably in the news media. Company Overall Sentiment AzurRx BioPharma Neutral ABVC BioPharma Neutral Which has more volatility and risk, AZRX or ABVC? AzurRx BioPharma has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, ABVC BioPharma has a beta of 0.33, suggesting that its stock price is 67% less volatile than the S&P 500. Do insiders & institutionals have more ownership in AZRX or ABVC? 6.3% of AzurRx BioPharma shares are held by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are held by institutional investors. 7.3% of AzurRx BioPharma shares are held by company insiders. Comparatively, 11.9% of ABVC BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation and earnings, AZRX or ABVC? ABVC BioPharma has higher revenue and earnings than AzurRx BioPharma. ABVC BioPharma is trading at a lower price-to-earnings ratio than AzurRx BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAzurRx BioPharmaN/AN/A-$32.67M-$11.50-0.03ABVC BioPharma$509.59K31.89-$10.52M-$0.47-2.19 SummaryABVC BioPharma beats AzurRx BioPharma on 9 of the 13 factors compared between the two stocks. Get AzurRx BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AZRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AZRX vs. The Competition Export to ExcelMetricAzurRx BioPharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.18M$6.84B$5.53B$7.93BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-0.037.3222.5118.54Price / SalesN/A241.49397.62103.34Price / CashN/A65.8538.1834.62Price / Book-0.456.486.734.25Net Income-$32.67M$143.41M$3.22B$248.18M AzurRx BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AZRXAzurRx BioPharmaN/A$0.34-3.2%N/A-86.9%$3.18MN/A-0.0312Gap UpABVCABVC BioPharma0.7582 of 5 stars$0.84-4.3%N/A-15.2%$13.18M$509,788.00-0.9730Earnings ReportGap DownIPAImmunoPrecise Antibodies2.7884 of 5 stars$0.41+1.7%$4.00+866.2%-65.2%$12.86M$24.00M-0.5380Short Interest ↓Gap UpMEIPMEI Pharma1.6048 of 5 stars$1.93+0.8%N/A-33.1%$12.83M$65.30M-0.34100Upcoming EarningsShort Interest ↑Gap UpIMNNImunon2.7305 of 5 stars$0.87-2.1%$21.50+2,371.3%-35.9%$12.74M$500,000.00-0.4630Short Interest ↓PHIOPhio Pharmaceuticals2.5244 of 5 stars$2.63-7.2%$4.00+52.4%-69.4%$12.54MN/A-0.2410Upcoming EarningsGap DownLSBLakeshore Biopharma1.3868 of 5 stars$1.35+5.1%N/AN/A$12.52M$672.27M0.00773Short Interest ↓Positive NewsGap UpRLMDRelmada Therapeutics4.3497 of 5 stars$0.37+14.9%$4.25+1,045.6%-91.1%$12.05MN/A-0.1310Upcoming EarningsHigh Trading VolumeTXMDTherapeuticsMD1.7632 of 5 stars$1.04+4.4%N/A-34.0%$12.04M$1.76M0.00420Analyst ForecastNERVMinerva Neurosciences3.803 of 5 stars$1.72+3.4%$5.00+191.4%-29.2%$12MN/A-3.909QNTMQuantum BiopharmaN/A$6.28+0.7%N/AN/A$11.99MN/A-0.41N/AUpcoming Earnings Related Companies and Tools Related Companies ABVC Alternatives IPA Alternatives MEIP Alternatives IMNN Alternatives PHIO Alternatives LSB Alternatives RLMD Alternatives TXMD Alternatives NERV Alternatives QNTM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AZRX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AzurRx BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AzurRx BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZRX Stock Free AZRX Stock Alerts